FAINARDI, ENRICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.295
EU - Europa 11.080
AS - Asia 9.339
SA - Sud America 2.095
AF - Africa 291
OC - Oceania 151
Continente sconosciuto - Info sul continente non disponibili 3
Totale 39.254
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.093
RU - Federazione Russa 3.898
PL - Polonia 3.046
SG - Singapore 2.640
CN - Cina 2.248
BR - Brasile 1.719
IT - Italia 1.506
VN - Vietnam 1.290
HK - Hong Kong 1.174
KR - Corea 857
IE - Irlanda 835
SE - Svezia 429
FR - Francia 335
IN - India 282
DE - Germania 268
GB - Regno Unito 201
BD - Bangladesh 169
ID - Indonesia 168
FI - Finlandia 156
AU - Australia 151
AR - Argentina 144
JP - Giappone 107
CA - Canada 102
NL - Olanda 99
CI - Costa d'Avorio 89
JO - Giordania 82
EC - Ecuador 75
ES - Italia 64
CH - Svizzera 60
MX - Messico 55
IQ - Iraq 52
UA - Ucraina 48
MA - Marocco 47
ZA - Sudafrica 46
CO - Colombia 44
TR - Turchia 35
NG - Nigeria 34
PY - Paraguay 34
SA - Arabia Saudita 30
PK - Pakistan 29
CL - Cile 25
BE - Belgio 23
AE - Emirati Arabi Uniti 20
UZ - Uzbekistan 20
VE - Venezuela 20
AT - Austria 17
AZ - Azerbaigian 17
EG - Egitto 16
CZ - Repubblica Ceca 15
PE - Perù 15
LT - Lituania 13
MY - Malesia 13
PH - Filippine 13
BJ - Benin 12
DZ - Algeria 12
RO - Romania 11
IL - Israele 10
KZ - Kazakistan 10
UY - Uruguay 10
GR - Grecia 9
KE - Kenya 9
AL - Albania 8
BO - Bolivia 8
DO - Repubblica Dominicana 8
JM - Giamaica 8
NP - Nepal 8
LV - Lettonia 7
PT - Portogallo 7
TH - Thailandia 7
TN - Tunisia 7
BH - Bahrain 6
GT - Guatemala 6
HN - Honduras 6
KG - Kirghizistan 6
SY - Repubblica araba siriana 6
ET - Etiopia 5
PS - Palestinian Territory 5
TT - Trinidad e Tobago 5
CY - Cipro 4
DK - Danimarca 4
IR - Iran 4
LB - Libano 4
PA - Panama 4
TW - Taiwan 4
AO - Angola 3
BG - Bulgaria 3
CR - Costa Rica 3
MD - Moldavia 3
QA - Qatar 3
TM - Turkmenistan 3
BN - Brunei Darussalam 2
EE - Estonia 2
MK - Macedonia 2
ML - Mali 2
MM - Myanmar 2
MN - Mongolia 2
NI - Nicaragua 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
Totale 39.226
Salva come PNG Salva come JPEG
Città #
Warsaw 3.041
Santa Clara 3.007
Ashburn 2.229
Singapore 2.022
Fairfield 1.718
Hong Kong 975
Seoul 839
Dublin 813
Woodbridge 786
Seattle 672
Houston 629
Hefei 581
Cambridge 563
Wilmington 512
San Jose 432
Ho Chi Minh City 427
Altamura 388
Beijing 384
Lawrence 311
Ann Arbor 286
Council Bluffs 279
Chandler 262
Hanoi 257
Lauterbourg 243
Florence 221
Princeton 216
Los Angeles 214
Boston 203
Moscow 195
The Dalles 187
Buffalo 175
Clifton 169
New York 168
Mumbai 151
Melbourne 147
São Paulo 131
Milan 103
San Diego 102
Munich 99
Jakarta 97
Helsinki 94
Kent 92
Tokyo 90
Abidjan 89
Dallas 84
Shanghai 69
Dong Ket 68
Medford 66
Rome 65
Da Nang 60
London 55
Haiphong 53
Bern 51
Phoenix 51
Rio de Janeiro 51
Boardman 50
Paris 48
Orem 47
Chicago 45
Redondo Beach 45
Frankfurt am Main 44
Falls Church 43
Toronto 39
Barcelona 38
Guangzhou 38
Hải Dương 33
Norwalk 33
Casablanca 31
Lappeenranta 31
Bengaluru 30
Bologna 30
Turku 30
Abuja 29
Amsterdam 28
Porto Alegre 28
Belo Horizonte 27
Chennai 27
Tianjin 26
Yubileyny 26
Baghdad 25
Biên Hòa 25
Brasília 25
Brooklyn 25
Guayaquil 25
Hillsboro 25
Thái Bình 25
Curitiba 24
Dearborn 23
Atlanta 22
Johannesburg 20
Manaus 20
Shenzhen 20
Guarulhos 19
Riyadh 19
Brussels 18
Denver 18
West Jordan 18
Amman 17
Manchester 17
Salvador 17
Totale 26.565
Salva come PNG Salva come JPEG
Nome #
Cerebrospinal fluid analysis and the determination of oligoclonal bands 315
Selezione all’intervento endovascolare tra perfusione e circoli collaterali 308
Definition of miRNAs Expression Profile in Glioblastoma Samples: The Relevance of Non-Neoplastic Brain Reference 304
Study of Soluble HLA-G in Congenital Human Cytomegalovirus Infection 300
Infection and HLA-G molecules in nasal polyposis 278
Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III 275
miRNAs expression analysis in paired fresh/Frozen and dissected formalin fixed and paraffin embedded glioblastoma using real-time PCR 274
A Practical Approach to Interpretation of CBF Measured by Mean of Xenon-CT in Patients with Traumatic Brain Injury 273
Association between perihematomal cerebral blood volume and intracerebral hemorrhage expansion: A computed tomography perfusion study 272
Amplitude Instability of Somatosensory Evoked Potentials as an Indicator of Delayed Cerebral Ischemia in a Case of Subarachnoid Hemorrhage 267
A semi-automated measuring system of brain diffusion and perfusion magnetic resonance imaging abnormalities in patients with multiple sclerosis based on the integration of coregistration and tissue segmentation procedures 257
A Commentary on the Use of Epstein-Barr Virus Specific Antibodies as Biological Markers in Multiple Sclerosis 257
Bimanual non-congruent actions in motor neglect syndrome: A combined behavioral/fMRI study 257
Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center? 257
Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis 249
Small Vessel Disease Is Associated with Tissue Inhibitor of Matrix Metalloproteinase-4 After Ischaemic Stroke 249
Computed Tomography Perfusion-Based Machine Learning Model Better Predicts Follow-Up Infarction in Patients with Acute Ischemic Stroke 247
Use of Noncontrast Computed Tomography and Computed Tomographic Perfusion in Predicting Intracerebral Hemorrhage after Intravenous Alteplase Therapy 243
Small vessel disease and biomarkers of endothelial dysfunction after ischaemic stroke 242
Reperfusion Injury after ischemic Stroke Study (RISKS): Single-centre (Florence, Italy), prospective observational protocol study 240
Significant low prevalence of antibodies reacting with simian virus 40 mimotopes in serum samples from patients affected by inflammatory neurologic diseases, including multiple sclerosis 240
Technical, Anatomical, and Functional Study after Removal of a Symptomatic Cavernous Angioma Located in Deep Wernicke's Territories with Cortico-Subcortical Awake Mapping 233
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 233
Temporal changes in blood-brain barrier permeability and cerebral perfusion in lacunar/subcortical ischemic stroke 232
Angioplasty in acute middle cerebral artery stroke due to atrial fibrillation selected by CT perfusion: A case report 228
Role of biological markers for cerebral bleeding risk STRATification in patients with atrial fibrillation on oral anticoagulants for primary or secondary prevention of ischemic stroke (Strat-AF study): Study design and methodology 224
History of migraine and volume of brain infarcts: The italian project on stroke at young age (IPSYS) 224
Cerebral small vessel disease and systemic arteriopathy in intracranial arterial dolichoectasia patients 223
Recent advances in our understanding of HLA-G biology: Lessons from a wide spectrum of human diseases 213
Cerebrospinal fluid amounts of HLA-G in dimeric form are strongly associated to patients with MRI inactive multiple sclerosis 207
Cerebral blood volume ASPECTS is the best predictor of clinical outcome in acute ischemic stroke: A retrospective, combined semi-quantitative and quantitative assessment 204
Determinants of cerebral collateral circulation in acute ischemic stroke due to large vessel occlusion 203
Intravenous thrombolysis or endovascular therapy for acute ischemic stroke associated with cervical internal carotid artery occlusion: the ICARO-3 study 202
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 202
Effect of the COVID-19 pandemic on disease activity in multiple sclerosis patients treated with hematopoietic stem cell transplantation 200
Quantitative Perfusion and Permeability Biomarkers in Brain Cancer from Tomographic CT and MR Images 200
Radiologic Cerebral Reperfusion at 24 h Predicts Good Clinical Outcome 200
Spinal cord size as promising biomarker of disability outcomes after hematopoietic stem cell transplantation in multiple sclerosis 198
MRI analysis of the "central vein sign" allows identification of a subset of relapsing remitting MS patients with brain pathology different from inflammatory demyelination 197
In vivo magnetic resonance imaging evidence of olfactory bulbs changes in a newborn with congenital Citomegalovirus: a case report 197
Some basic aspects of HLA-G biology 196
Can CHA2DS2-VASc and HAS-BLED Foresee the Presence of Cerebral Microbleeds, Lacunar and Non-Lacunar Infarcts in Elderly Patients With Atrial Fibrillation? Data From Strat-AF Study 195
Prognostic role of intrathecal IgM synthesis in multiple sclerosis: Results from a clinical series 195
Chlamydophila pneumoniae infection and its role in neurological disorders 192
HLA-G molecules in autoimmune diseases and infections 191
CT perfusion and angiographic assessment of pial collateral reperfusion in acute ischemic stroke: The CAPRI study 189
Correlation between auto/mitophagic processes and magnetic resonance imaging activity in multiple sclerosis patients 188
Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies 187
KIR2DL2 inhibitory pathway enhances Th17 cytokine secretion by NK cells in response to herpesvirus infection in multiple sclerosis patients 182
Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis 181
Accuracy of the central vein sign evaluation by brain MRI for the pathologic characterization of multiple sclerosis cases with markers of "better explanation" of the diagnosis. 179
Integrating novel neuroimaging measurements and circulating biomarkers for the prediction of secondary injury following stroke. the NIMBLE study. 178
Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study 178
Cerebrospinal fluid analysis and the determination of oligoclonal bands 177
Conventional and Advanced Magnetic Resonance Imaging Assessment of Non-Enhancing Peritumoral Area in Brain Tumor 176
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment 174
Prevalence of non-stenotic vulnerable carotid plaques in embolic stroke of undetermined source 173
Incidence of neuroepithelial primary brain tumors among adult population of Emilia-Romagna Region, Italy 172
Acute Multi-modal Neuroimaging in a Porcine Model of Endothelin-1-Induced Cerebral Ischemia: Defining the Acute Infarct Core 171
Leptomeningeal enhancement in multiple sclerosis: a focus on patients treated with hematopoietic stem cell transplantation 170
Subarachnoid Extension Predicts Lobar Intracerebral Hemorrhage Expansion 170
Association Between Motor and Cognitive Performances in Elderly With Atrial Fibrillation: Strat-AF Study 170
An acutely confused young woman 169
Added value of multiphase CTA imaging for thrombus perviousness assessment 168
Endovascular Thrombectomy for Acute Ischemic Stroke Beyond 6 Hours From Onset: A Real-World Experience 167
Herpesvirus Infections in KIR2DL2-Positive Multiple Sclerosis Patients: Mechanisms Triggering Autoimmunity 167
CT perfusion cerebral blood volume does not always predict infarct core in acute ischemic stroke 166
Multiplex matrix metalloproteinases analysis in the cerebrospinal fluid reveals potential specific patterns in multiple sclerosis patients 165
Sex differences in outcome after thrombectomy for acute ischemic stroke. A propensity score-matched study 164
Cognitive phenotypes and factors associated with cognitive decline in a cohort of older patients with atrial fibrillation: The Strat-AF study 164
Differentiation by MRI between multiple sclerosis and MS-like syndromes with markers of "better explanation" of the diagnosis. 164
Pivotal role of multiphase computed tomography angiography for collateral assessment in patients with acute ischemic stroke 163
Altered miRNA expression in T regulatory cells in course of multiple sclerosis 163
Multicentre longitudinal study of fluid and neuroimaging BIOmarkers of AXonal injury after traumatic brain injury: The BIO-AX-TBI study protocol 163
Blood–brain barrier leakage and hemorrhagic transformation: The Reperfusion Injury in Ischemic StroKe (RISK) study 163
Investigating Serum sHLA-G Cooperation With MRI Activity and Disease-Modifying Treatment Outcome in Relapsing-Remitting Multiple Sclerosis 162
IV thrombolysis plus thrombectomy versus IV thrombolysis alone for minor stroke with anterior circulation large vessel occlusion from the IRETAS and Italian SITS-ISTR cohorts 161
The role of HLA-Class Ib molecules in immune-related diseases, tumors, and infections 161
Sexual dimorphism in the cerebrospinal fluid total protein content 160
Mechanical thrombectomy in patients with heart failure: the Italian registry of Endovascular Treatment in Acute Stroke 159
Blood-Brain Barrier Disruption and Hemorrhagic Transformation in Acute Ischemic Stroke: Systematic Review and Meta-Analysis 159
25-Hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis 158
Assessment of HIV-intrathecal humoral immune response in AIDS-related neurological disorders 156
Translational stroke research review: Using the mouse to model human futile recanalization and reperfusion injury in ischemic brain tissue 156
Matrix metalloproteinases (MMP): Determination of different forms by different techniques may require different preanalytical strategies [2] 155
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 155
MS patients with low central vein sign frequency can be identified by FLAIR* MRi sequences 154
Functional outcomes, extent of resection, and bright/vague fluorescence interface in resection of glioblastomas involving the motor pathways assisted by 5-ALA 153
Case report: 3D intracranial vessel wall MRI in Susac syndrome: potential relevance for diagnosis and therapeutic management 152
Non-contrast CT markers of intracerebral hemorrhage expansion: the influence of onset-to-CT time. 151
Heads-Up Micronavigation Reliability of Preoperative Transcranial Magnetic Stimulation Maps for the Motor Function: Comparison With Direct Cortical Stimulation 150
The role of extracellular matrix and inflammation in the stratification of bleeding and thrombotic risk of atrial fibrillation on oral anticoagulant therapy: insights from Strat-Af study 150
Temporal changes in perihematomal apparent diffusion coefficient values during the transition from acute to subacute phases in patients with spontaneous intracerebral hemorrhage 150
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 150
Characteristics of Early Presenters after Intracerebral Hemorrhage 149
A generalized parametric response mapping method for analysis of multi-parametric imaging: A feasibility study with application to glioblastoma 149
Stroke with large vessel occlusion in the posterior circulation: IV thrombolysis plus thrombectomy versus IV thrombolysis alone 148
Tmax Volumes Predict Final Infarct Size and Functional Outcome in Ischemic Stroke Patients Receiving Endovascular Treatment 148
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 147
Acute ischemic STROKE - from laboratory to the Patient's BED (STROKELABED): A translational approach to reperfusion injury. Study Protocol 146
Totale 19.593
Salva come PNG Salva come JPEG
Categoria #
all - tutte 114.795
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.795
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021265 0 0 0 0 0 0 0 0 0 0 125 140
2021/20221.540 59 93 159 71 48 97 59 172 90 78 160 454
2022/20232.861 327 770 102 109 104 508 431 103 239 29 71 68
2023/20241.676 28 215 262 68 117 138 75 356 60 144 111 102
2024/202510.159 429 1.234 805 1.589 2.601 1.237 183 408 526 300 379 468
2025/202614.304 1.236 2.115 1.675 2.401 1.469 479 1.379 853 950 1.035 712 0
Totale 39.759